This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dial S et al. (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294: 2989–2995
Zedtwitz-Liebenstein K et al. (2002) Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30: 1118–1122
Geevasinga N et al. (2006) Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol 4: 597–604
Yang YX et al. (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296: 2947–2953
Fuhrmans V (2007) Withdrawal treatment: a novel plan helps hospital wean itself off pricey tests. Wall St J (12 January 2007) A1, A11
Acknowledgements
The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Patel, V., Fordtran, J. Hazards of PPI overuse and possible ways to curtail it. Nat Rev Gastroenterol Hepatol 4, 246–247 (2007). https://doi.org/10.1038/ncpgasthep0788
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ncpgasthep0788